Why is Caplin Point Lab falling/rising?

As of 12-Sep, Caplin Point Laboratories Ltd is experiencing a slight increase in its stock price, currently at 2,240.70, with a change of 4.1 (0.18%) upwards. The stock has shown strong performance recently, gaining 6% over the last six days and outperforming the benchmark Sensex with a weekly return of 4.88% compared to the Sensex's 1.48%. Additionally, the stock is trading above its moving averages across various time frames, indicating positive momentum. The company has demonstrated high management efficiency with a return on equity (ROE) of 19.84% and has maintained a low debt-to-equity ratio. Furthermore, it has reported positive results for the last 12 consecutive quarters, with record net sales and profit after tax, which has likely contributed to the recent upward movement in stock price.
In the broader market context, Caplin Point Laboratories Ltd's short-term performance is significantly stronger than the benchmark, as evidenced by its 1-week return of 4.88% versus the Sensex's 1.48%. The stock has also seen increased participation from institutional investors, who have raised their stake by 0.65% in the last quarter, indicating growing confidence in the company's fundamentals. This rising investor interest, combined with consistent returns over the last three years, where the stock has outperformed the BSE500, suggests a positive outlook that may be driving the stock's recent gains.